Not all clients with CLL demand therapy. In spite of all current advances, the iwCLL however suggests watchful observation for patients with asymptomatic disease.86 This recommendation is based on a minimum of two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both equally trials https://louisoyhox.livebloggs.com/38794995/link-alternatif-mbl77-options